Bank Of America Corp Tff Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.77 $639 - $1,145	-1,488 Reduced 30.54%	3,384 $1,000
Q1 2023 May 12, 2023	BUY	$0.62 - $1.1 $874 - $1,551	1,410 Added 40.73%	4,872 $3,000
Q4 2022 Feb 10, 2023	SELL	$0.84 - $100.75 $121 - $14,608	-145 Reduced 4.02%	3,462 $3,000
Q3 2022 Nov 14, 2022	SELL	$4.61 - $116.0 $19,901 - $500,772	-4,317 Reduced 54.48%	3,607 $15,000
Q2 2022 Aug 12, 2022	BUY	$3.99 - $7.22 $18,114 - $32,778	4,540 Added 134.16%	7,924 $44,000
Q1 2022 May 16, 2022	SELL	$5.28 - $9.17 $211 - $366	-40 Reduced 1.17%	3,384 $21,000
Q4 2021 Feb 08, 2022	BUY	$6.86 - $9.65 $11,483 - $16,154	1,674 Added 95.66%	3,424 $30,000
Q2 2021 Sep 13, 2021	BUY	$8.48 - $13.61 $14,840 - $23,817	1,750 New	1,750 $17,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.